Insight Molecular Diagnostics Inc. (IMDX)
NASDAQ: IMDX · Real-Time Price · USD
4.220
+0.300 (7.65%)
At close: Mar 20, 2026, 4:00 PM EDT
4.260
+0.040 (0.95%)
After-hours: Mar 20, 2026, 4:10 PM EDT
IMDX Market Cap
IMDX has a market cap or net worth of $122.11 million as of March 20, 2026. Its market cap has increased by 99.20% in one year.
Market Cap
122.11M
Enterprise Value
106.55M
1-Year Change
99.20%
Ranking
Category
Stock Price
$4.22
Market Cap Chart
Since January 4, 2016, IMDX's market cap has decreased from $228.70M to $122.11M, a decrease of -46.61%. That is a compound annual growth rate of -5.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 122.10M | -43.21% |
| Dec 31, 2025 | 215.00M | 436.16% |
| Dec 31, 2024 | 40.10M | 93.72% |
| Dec 29, 2023 | 20.70M | -45.67% |
| Dec 30, 2022 | 38.10M | -80.96% |
| Dec 31, 2021 | 200.10M | 24.52% |
| Dec 31, 2020 | 160.70M | 37.47% |
| Dec 31, 2019 | 116.90M | 108.38% |
| Dec 31, 2018 | 56.10M | -61.60% |
| Dec 29, 2017 | 146.10M | -27.82% |
| Dec 30, 2016 | 202.40M | -11.50% |
| Jan 4, 2016 | 228.70M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Castle Biosciences | 764.09M |
| Personalis | 752.30M |
| Fulgent Genetics | 485.95M |
| Burning Rock Biotech | 475.69M |
| Myriad Genetics | 444.16M |
| Prenetics Global | 355.92M |
| MDxHealth | 161.36M |
| Biodesix | 160.69M |